Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …

Governed by parasite and host factors and immunoinflammatory responses, the clinical
spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions) …

Established models of T-helper-2-cell dominance in BALB/c mice infected with Leishmania
major—involving the early production of interleukin-4 by a small subset of Leishmania …

The 20 or so species of Leishmania which have been recorded as human infections are all
either zoonotic, or have recent zoonotic origins. Their distribution is determined by that of …

A number of leishmaniasis vaccine candidates are at various stages of pre-clinical and
clinical development. Leishmaniasis is a vector-borne neglected tropical disease (NTD) …

Numerous epidemiological and clinical studies have noted differences in the incidence and
severity of parasitic diseases between males and females. Although in some instances this …

Leishmaniae are obligatory intracellular protozoa in mononuclear phagocytes. They cause a
spectrum of diseases, ranging in severity from spontaneously healing skin lesions to fatal …

Leishmaniasis is a parasitic disease that encompasses a range of clinical manifestations
affecting people in tropical and subtropical regions of the world. Epidemiological and …

Background Recent circumstantial evidence suggests that an increasing number of Iranian
patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate …

Cutaneous Leishmaniasis: Recognition and Treatment | AAFP Advertisement search close
brand logo WILLIAM H. MARKLE, MD, AND KHALDOUN MAKHOUL, MD Am Fam Physician …